Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hookipa Pharma (HOOK – Research Report), Olink Holding (OLK – Research Report) and Pfizer (PFE – Research Report). Hookipa Pharma (HOOK) SVB Securities analyst Andrew Berens maintained a Buy rating on Hookipa Pharma yesterday. The company's shares closed last Monday at $1.55, close to its 52-week low of $1.25. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-hookipa-pharma-hook-olink-holding-olk-and-pfizer-pfe?utm_source=advfn.com&utm_medium=referral